Other
Maple Leaf Research
Total Trials
5
Recruiting
1
Active
2
Completed
3
Success Rate
100.0%+13% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 15/100
Failure Rate
0.0%
0 terminated/withdrawn out of 5 trials
Success Rate
100.0%
+13.5% vs industry average
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
67%
2 of 3 completed trials have results
Key Signals
1 recruiting2 with results
Enrollment Performance
Analytics
Phase 4
2(40.0%)
N/A
2(40.0%)
Phase 2
1(20.0%)
5Total
Phase 4(2)
N/A(2)
Phase 2(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (5)
Showing 5 of 5 trials
NCT06823596Not ApplicableRecruiting
The T Cell Activator of Cell Killing ("TACK") IT ON" STUDY
Role: collaborator
NCT05097430Not ApplicableCompleted
PrEP and Alcohol - Enhancing HIV Pre-Exposure Prophylaxis (PrEP)
Role: collaborator
NCT05663892Phase 4Active Not Recruiting
Drug-Drug Interaction Study in Trans Women Living With HIV
Role: lead
NCT02149888Phase 4Completed
PRe-Exposure Prophylaxis Acceptability & Readiness Assessments for Toronto gaY, Bisexual and Other Men Who Have Sex With Men-5
Role: collaborator
NCT01154673Phase 2Completed
Effects of Intensive cART During Acute/Early HIV Infection
Role: collaborator
All 5 trials loaded